Stockscreener 앱 받기
1.70
8.60%
-0.16
시간 외 거래:
1.76
0.06
+3.53%
전일 마감가:
$1.86
열려 있는:
$1.84
하루 거래량:
164.77K
Relative Volume:
0.14
시가총액:
$18.34M
수익:
$144.00K
순이익/손실:
$-14.50M
주가수익비율:
-1.1723
EPS:
-1.4501
순현금흐름:
$-14.95M
1주 성능:
-31.17%
1개월 성능:
-31.17%
6개월 성능:
-68.86%
1년 성능:
-63.04%
1일 변동 폭
$1.6506
$1.84
1주일 범위
$1.6506
$2.47
52주 변동 폭
$1.6506
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
명칭
Serina Therapeutics Inc
전화
(256) 327-9630
주소
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
1.70 | 20.06M | 144.00K | -14.50M | -14.95M | -1.4501 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-14 | 개시 | H.C. Wainwright | Buy |
Serina Therapeutics Inc 주식(SER)의 최신 뉴스
Aug Drivers: Whats next for Marchex Inc stockShort Setup & Reliable Breakout Stock Forecasts - baoquankhu1.vn
Serina Therapeutics CSO sells $19,680 in shares By Investing.com - Investing.com South Africa
Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event - The Globe and Mail
Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event - Finviz
Bull Bear: Is Serina Therapeutics Inc a stock for growth or value investorsTrade Entry Summary & Smart Swing Trading Techniques - baoquankhu1.vn
Stock Recap: Is Serina Therapeutics Inc a stock for growth or value investorsEarnings Performance Report & High Conviction Investment Ideas - baoquankhu1.vn
Why did SER stock surge over 70% in pre-market today? - MSN
Bull Run: What are Serina Therapeutics Incs recent SEC filings showingMarket Growth Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Serina Therapeutics CSO sells $23,185 in shares By Investing.com - Investing.com Canada
Serina Therapeutics CSO sells $23,185 in shares - Investing.com
Serina Therapeutics Stock Soars Amid Strategic Partnership Announcements - StocksToTrade
Serina Therapeutics Announces FDA Clearance of IND - GlobeNewswire
Serina Jumps On FDA's IND Clearance For SER-252 In Advanced Parkinson's Disease After Clinical Hold - Nasdaq
What Sparked Serina Therapeutics (SER) 35% After-Hours Surge? - Finviz
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug By Investing.com - Investing.com South Africa
Serina Therapeutics stock soars after FDA clears IND for Parkinson’s drug - Investing.com UK
Serina Therapeutics announces FDA clearance of IND application for SER-252 for the treatment of advanced Parkinson's disease - marketscreener.com
Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s disease - The Manila Times
Serina Therapeutics, Inc. Announces FDA Clearance for SER-252 IND - TradingView
FDA clears trial of new advanced Parkinson’s therapy SER-252 - stocktitan.net
New Highs: Why is Serina Therapeutics Inc stock going upJuly 2025 Update & Weekly Breakout Stock Alerts - baoquankhu1.vn
Serina Therapeutics CSO sells $7375 in shares By Investing.com - Investing.com Canada
Aug Technicals: Is Serina Therapeutics Inc benefiting from innovation trends2025 Biggest Moves & Daily Growth Stock Investment Tips - baoquankhu1.vn
Serina Therapeutics CSO sells $12,140 in shares By Investing.com - Investing.com UK
Serina Therapeutics CSO sells $12,140 in shares - Investing.com
Geopolitics Watch: Why is Serina Therapeutics Inc stock going upTrade Risk Summary & Accurate Trade Setup Notifications - baoquankhu1.vn
Winners Losers: What is the dividend yield of Serina Therapeutics IncJuly 2025 Action & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Serina Therapeutics receives NYSE notification - MSN
Serina Therapeutics (SER) Receives NYSE Deficiency Notice for Low Stockholders' Equity - Intellectia AI
Serina Therapeutics Faces NYSE American Compliance Deficiency Notice - The Globe and Mail
Serina Therapeutics Receives NYSE Deficiency Notice; Stock Edges Down - Nasdaq
Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity - The Globe and Mail
Serina Therapeutics receives NYSE listing deficiency notice - Investing.com
Serina Therapeutics Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Serina Therapeutics receives NYSE listing deficiency notice By Investing.com - Investing.com Nigeria
Serina Therapeutics CSO Moreadith sells shares for $16,253 - Investing.com
Serina Therapeutics CSO Moreadith sells shares for $16,253 By Investing.com - Investing.com Australia
What is the fair value of Serina Therapeutics Inc. stock nowJuly 2025 Selloffs & Weekly Market Pulse Updates - ulpravda.ru
Serina Therapeutics CSO Moreadith sells $34,953 in shares By Investing.com - Investing.com Canada
Serina Therapeutics (SER) Chief Scientific Officer reports 13,000-share sale - Stock Titan
Will Serina Therapeutics Inc. (2BO) stock split increase liquidityWide Width Options & walk-ready comfort choices - ulpravda.ru
Serina Therapeutics, Inc. Common Stock (NYSE:SER) Stock Quote - FinancialContent
Buybacks Report: How supply chain issues affect Serina Therapeutics Inc. stockQuarterly Profit Review & Technical Pattern Based Buy Signals - Улправда
Will Serina Therapeutics Inc. stock continue dividend increasesPortfolio Risk Report & Long Hold Capital Preservation Tips - Улправда
Why Serina Therapeutics Inc. stock attracts global investorsWeekly Trade Review & AI Forecast for Swing Trade Picks - ulpravda.ru
Is Serina Therapeutics Inc. (2BO) stock good for long term investingJuly 2025 Opening Moves & Capital Efficiency Focused Strategies - Улправда
Serina Therapeutics Inc (SER) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):